Neurotoxins and pore forming toxins in sea anemones: Potential candidates for new drug development

被引:4
|
作者
Wang, Zhi-Lin [1 ]
Zhang, Shu-Yi [1 ]
Hao, Shuang-Li [1 ,2 ]
Yang, Wan -Xi [1 ,2 ]
机构
[1] Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou, Peoples R China
[2] Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310058, Peoples R China
基金
中国国家自然科学基金;
关键词
Sodium channel toxins; Potassium channel toxins; Cytolysin; Organs; Diseases; AMINO-ACID-SEQUENCE; POTASSIUM-CHANNEL TOXIN; POLYPEPTIDE ANTHOPLEURIN-B; SINGLE SODIUM-CHANNELS; HIGH-AFFINITY BINDING; ISOLATED RAT-HEART; MEMORY T-CELLS; EQUINATOXIN-II; ACTINIA-EQUINA; ATX-II;
D O I
10.14670/HH-18-500
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
There are two kinds of toxins in sea anemones: neurotoxins and pore forming toxins. As a representative of the sodium channel toxin, the neurotoxin ATX II in neurotoxin mainly affects the process of action potential and the release of transmitter to affect the inactivation of the sodium channel. As the representatives of potassium channel toxins, BgK and ShK mainly affect the potassium channel current. EqTx and Sticholysins are representative of pore forming toxins, which can form specific ion channels in cell membranes and change the concentration of internal and external ions, eventually causing hemolytic effects. Based on the above mechanism, toxins such as ATX II can also cause toxic effects in tissues and organs such as heart, lung and muscle. As an applied aspect it was shown that sea anemone toxins often have strong toxic effects on tumor cells, induce cancer cells to enter the pathway of apoptosis, and can also bind to monoclonal antibodies or directly inhibit relevant channels for the treatment of autoimmune diseases.
引用
收藏
页码:9 / 28
页数:20
相关论文
共 50 条
  • [31] Development of new methods for the asymmetric synthesis of small molecule drug candidates
    Walker, Shawn D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [32] A new understanding of Acanthamoeba castellanii: dispelling the role of bacterial pore-forming toxins in cyst formation and amoebicidal actions
    Yabrag, Abdelbasset
    Ullah, Naeem
    Baryalai, Palwasha
    Ahmad, Irfan
    Zlatkov, Nikola
    Toh, Eric
    Lindback, Toril
    Uhlin, Bernt Eric
    Wai, Sun Nyunt
    Nadeem, Aftab
    CELL DEATH DISCOVERY, 2025, 11 (01)
  • [33] New Compounds and Potential Candidates for Drug Discovery from Medicinal Plants of Vietnam
    Phan Minh Giang
    Otsuka, Hideaki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2018, 66 (05) : 493 - 505
  • [34] TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates
    Socala, Katarzyna
    Jakubiec, Marcin
    Abram, Michal
    Mlost, Jakub
    Starowicz, Katarzyna
    Kaminski, Rafal M.
    Ciepiela, Katarzyna
    Andres-Mach, Marta
    Zagaja, Miroslaw
    Metcalf, Cameron S.
    Zawadzki, Przemyslaw
    Wlaz, Piotr
    Kaminski, Krzysztof
    PROGRESS IN NEUROBIOLOGY, 2024, 240
  • [35] Useful Methods for Targeted Plant Selection in the Discovery of Potential New Drug Candidates
    Schwikkard, Sianne L.
    Mulholland, Dulcie A.
    PLANTA MEDICA, 2014, 80 (14) : 1154 - 1160
  • [36] Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
    Bahia, Maria T.
    Nascimento, Alvaro F. S.
    Mazzeti, Ana Lia
    Marques, Luiz F.
    Goncalves, Karolina R.
    Mota, Ludmilla W. R.
    Diniz, Livia de F.
    Caldas, Ivo S.
    Talvani, Andre
    Shackleford, David M.
    Koltun, Maria
    Saunders, Jessica
    White, Karen L.
    Scandale, Ivan
    Charman, Susan A.
    Chatelain, Eric
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (08) : 4362 - 4370
  • [37] Current progress in identifying endogenous biomarker candidates for drug transporter phenotyping and their potential application to drug development
    Mochizuki, Tatsuki
    Mizuno, Tadahaya
    Maeda, Kazuya
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2021, 37
  • [38] Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells
    Soletti, Rossana C.
    de Faria, Giselle Pinto
    Vernal, Javier
    Terenzi, Hernan
    Anderluh, Gregor
    Borges, Helena L.
    Moura-Neto, Vivaldo
    Gabilan, Nelson H.
    ANTI-CANCER DRUGS, 2008, 19 (05) : 517 - 525
  • [39] A new species, Adamsia obvolva (Cnidaria: Anthozoa: Actiniaria), from the Gulf of Mexico, and a discussion of the taxonomy of carcinoecium-forming sea anemones
    Daly, M
    Ardelean, A
    Cha, HR
    Campbell, AC
    Fautin, DG
    BULLETIN OF MARINE SCIENCE, 2004, 74 (02) : 385 - 399
  • [40] Evaluation of kappa carrageenan as potential carrier for floating drug delivery system: Effect of pore forming agents
    Selvakumaran, Suguna
    Muhamad, Ida Idayu
    Abd Razak, Saiful Izwan
    CARBOHYDRATE POLYMERS, 2016, 135 : 207 - 214